March 12, 2026 (12:00)
“New Insights into Risk Stratification for T-cell acute lymphoblastic leukemia”
Dr David T. Teachey
Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania
The host of this seminar are Eulàlia Genescà and Pablo Menéndez.
David T. Teachey, MD is a Professor of Pediatrics and the Garrett Brodeur, MD Endowed Chair in Oncology at the Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania. He is an attending physician in the Division of Oncology at the Children’s Hospital of Philadelphia. He is an R01-funded physician-scientist with clinical and research expertise focused on improving the understanding of disease biology and the translation of novel therapies for children with acute lymphoblastic leukemia (ALL) and rare inherited autoimmune diseases. He is the PI on multiple local, national, and international clinical trials and often performs the correlative studies for those trials in his lab. He is the Chair of the ALL Disease Committee for the Children’s Oncology Group (COG) and Co-Leader of the Immune Dysregulation Frontier Program at CHOP.
IJC Auditorium + Online
Registration here